HIV / AIDs
Genomics and Epigenetics
Local Medical Scene
Best Medical Staff Awards
Bulletins From Thai MOPH/Thai FDA
Medical Stock Market
Thailand Medical News TV
Thailand Medical News Credit Card
Medical Schools Listings
Medical Organizations Listings
Thai Medical Drug Listings
Inter Drug Companies Listings
Medical Pharmacies Listings
Diaganostic Labs Listings
Medical Health A-Z
Drugs Info A-Z
Medical Devices Directory
UCLA Scientists create a renewable source of cancer-fighting T cells from pluripotent stem cells
US FDA STARTS PROBE AND ISSUE DOCTOR WARNINGS! Paclitaxel-Coated Devices for PAD Potentially Tied to Increased Deaths.
The New Sexually-Transmitted Epidemic In Asia
HKU Discovers A New Broad Spectrum Antiviral Drug, AM580
Ibrutinib, A New and Better Drug For Leukemia
Drug That Stop Cancer Metastasis Finally Identified.
Therapeutic Protein, Tinagl1 shows positive results against triple-negative breast cancer.
New Rapid and Economical Tests to help predict risk of Metastasis in Prostrate Cancer Patients.
Antibiotic Resistant Escheria Coli In Thailand’s Neighbour, Vietnam could pose a Nightmare for the Asian Region.
Breast Cancer Drug; Letrozole found to impair brain function. Countries like India have already banned the usage of the drug.
Blood Pressure Drug, Losartan Recalled Due To Carcinogenic Contamination
Thai FDA joins USFDA and other countries in recalling heart drug, Valsartan due to impurities
Medical Spheres Co., Ltd.
622, Emporium Tower, 10/1, 10th Fl
Sukhumvit Road, Klongton, Bangkok 10110
General Enquiries (English)
General Enquiries (Thai)
Advertising & Sponsorship
PR News Contribution
FROM HIV / AIDS
Study Of NEF Protein Released Due To HIV Infection Could Lead To New Therapeutic Developments
Targeting HIV Viral Reservoirs – The Next Frontier in the AIDS Battle.
Study shows that Testosterone may aid HIV male patients with better BMD (bone mineral density).
HIV latency in the various body tissues varies.
Future Trends In PrEP, moving beyond Truvada.
New single-tablet regimens show long-term effectiveness in HIV management according to studies.
LATEST ON PR RELEASES
Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High Hepatocellular Carcinoma Patients
Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection
AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines
Phase III data showed that Venclexta Venclyxto plus Gazyva Gazyvaro reduced the risk of disease worsening or death in people with previously untreated chronic lymphocytic leukaemia with co-morbidities
Phase III HARMONIZE Global trial of Lokelma confirms efficacy in maintaining normal potassium levels in Asian patients with hyperkalaemia
Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, Evobrutinib In RMS.